Clinically, we found the co-localization of TLR3, PRMT5 and c-Myc within the nuclei of cancer cells presented in tumor tissue sections obtained from pancreatic cancer patients undergoing neoadjuvant chemotherapy. Here, PRMT5 is linked to neoplasm.